Exicure Inc (XCUR) is a Healthcare · Biotechnology company listed on NASDAQ. Price $1.23 (-8.89%), Market cap $0.02B, 52-week low–high $3.24 ~ $11.86.
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.
Financial statements, price targets, institutional (13F) holdings and related news for Exicure Inc are updated in real time on BlackAll Trade.
Exicure Inc trades at $1.23 (-8.89%). Real-time quotes and charts are available on BlackAll Trade.
Exicure Inc has a market cap of about $0.02B.
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development a